Skip to main content
. 2017 Jul 28;38(4):2078–2086. doi: 10.3892/or.2017.5854

Figure 2.

Figure 2.

The prognostic value of miR-616 in NSCLC patients. (A) The overall and (B) disease-free survival rate were compared between patients with a high expression level of miR-616 and those with a low expression level of miR-616. NSCLC, non-small cell lung cancer.